How Serious Is Cutaneous Lupus? Types & Treatment

How Serious Is Cutaneous Lupus
Cutaneous lupus is a type of lupus characterized by a red, scaly rash on the skin

Cutaneous lupus is a type of lupus—an autoimmune disease that causes the body to attack healthy tissues—characterized by a red, scaly rash on the skin

Though the condition is not contagious or life-threatening, cutaneous lupus rashes can cause long-term damage, such as scarring, skin discoloration, and permanent hair loss if left untreated.

Approximately 5%-25% of patients with cutaneous lupus can develop systemic lupus with primarily mucocutaneous and musculoskeletal manifestations. Discoid lupus erythematosus can potentially develop into skin cancer if left untreated for a long time.

What are different types of cutaneous lupus?

Cutaneous lupus erythematosus most commonly affects people with systemic lupus erythematosus (SLE). There are three types:

  • Acute cutaneous lupus: Characterized by a butterfly-shaped (malar) rash on the cheeks and nose triggered by sunlight exposure.
  • Subacute cutaneous lupus erythematosus: Characterized by either ring-shaped red patches with scaly borders and lighter centers or scaly red bumps on sun-exposed areas.
  • Chronic or discoid cutaneous lupus erythematosus: Characterized by red scaly plaques (disc-shaped) lesions with both light and dark pigmentation, pain, itching, burning, scarring, and skin thinning.

How is cutaneous lupus treated?

While there is no cure for cutaneous lupus, symptoms can be managed with medications and lifestyle changes:

Check Also

Heparin: Blood Clot Uses, Warnings, Side Effects, Dosage

Generic Name: heparin Drug Class: Anticoagulants, Cardiovascular; Anticoagulants, Hematologic What is heparin, and what is it used for? Heparin is a natural anticoagulant compound in the body that prevents the formation of blood clots (thrombosis). Heparin used as medication is commercially prepared from animal mucous tissue such as ox lungs and pig intestines. Heparin is administered …

Leave a Reply